Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Patient-specific antiplatelet therapy.

Ian D Conde1, Neal S Kleiman

  • 1Division of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.

Journal of Thrombosis and Thrombolysis
|July 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Balloon-Assisted Leaflet Laceration Using Modified UNICORN Technique in Native Valve TAVR.

JACC. Case reports·2026
Same author

10-year experience with transcatheter aortic valve explants in a high-volume center.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Impact of Concomitant Mitral Regurgitation in Moderate Aortic Stenosis: Assessment of Remodeling and Clinical Outcomes.

JACC. Cardiovascular imaging·2026
Same author

Impact of IVUS Guidance on Clinical and Procedural Outcomes in Intracoronary Brachytherapy.

JACC. Advances·2026
Same author

Tricuspid Transcatheter Edge-to-Edge Repair in Orthotopic Heart Transplantation Recipients.

JACC. Case reports·2026
Same author

Clinical Profile and Outcomes of Patients Deemed Ineligible for Transcatheter Tricuspid Valve Intervention.

The Canadian journal of cardiology·2026

Anti-platelet drugs like aspirin and thienopyridines are crucial for preventing thrombotic cardiovascular diseases. Patient characteristics significantly impact the efficacy and safety of these vital anti-platelet agents.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Platelets are central to thrombosis and are primary targets for treating and preventing thrombotic cardiovascular diseases.
  • Current anti-platelet therapies include aspirin, thienopyridines, and GPIIb/IIIa antagonists.

Purpose of the Study:

  • To review the three main classes of anti-platelet drugs.
  • To discuss patient characteristics influencing anti-platelet agent efficacy and safety.

Main Methods:

  • Literature review of anti-platelet agents.
  • Analysis of patient factors affecting drug outcomes.

Main Results:

  • Aspirin, thienopyridines, and GPIIb/IIIa antagonists are established anti-platelet therapies.
  • Individual patient factors can alter the effectiveness and side effect profiles of these drugs.

Related Experiment Videos

Conclusions:

  • Understanding patient-specific factors is essential for optimizing anti-platelet therapy.
  • Tailoring anti-platelet treatment based on patient characteristics can improve outcomes in thrombotic cardiovascular diseases.